Read + Share
Amedeo Smart
Independent Medical Education
Tsukaguchi A, Tamiya A, Fukuda S, Iwahashi Y, et al. Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer. Anticancer Res 2024;44:4517-4524.PMID: 39348997
Email
LinkedIn
Privacy Policy